GlassScriptPhysician profile
John David Allen
NPI 1386628907
$462.07
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.91 · 2020: $64.50 · 2021: $56.72 · 2022: $109 · 2023: $154 · 2024: $23.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $142.04 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.14 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $54.03 | 2020-2023 | Jornay Pm |
| Corium, LLC | $50.78 | 2022-2023 | Azstarys |
| Mindray Ds USA, INC. | $46.08 | 2022 | |
| Sanofi Pasteur INC. | $39.19 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $21.10 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.06 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.66 | 2021 | |
| Neos Therapeutics, LP | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.